Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove Prevention Professionals
- Remove Substance Abuse
- Remove Alcohol Abuse
- Remove People with Substance Use or Abuse Problems as Population Group
- Remove People with Alcohol Use or Abuse Problems as Population Group
- Remove People with Mental Health Problems as Population Group
- Remove College Students as Population Group
- Remove Hispanic or Latino
- Remove Illegal Drugs
- Remove Opioids or Opiates
- Remove Prescription Drugs
- Remove Dextromethorphan
- Remove Heroin
- Remove Illicit Stimulants
Main page content
Published: November 2021
This Advisory reviews the evidence on prescription stimulant misuse among youth and young adults. It establishes prescription stimulant misuse as a public health problem, identifies associated risk and protective factors, and provides programs and action steps for stakeholders to prevent misuse.
Published: January 2021
The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).
The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue (Spanish version) - La crisis de los opioides en la población Hispana/Latina: un asunto urgente
Published: October 2020
Issue brief presents recent data on prevalence of opioid misuse & death rates in the Hispanic/Latino population; contextual factors & challenges to prevention & treatment; innovative outreach & engagement strategies to connect people to evidence-based treatment; & the importance of community voice.
Key Substance Use and Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health
Published: September 2017
This report presents 2016 national estimates of use of alcohol, tobacco products, illicit drugs (such as, marijuana, cocaine, heroin, hallucinogens, and inhalants, as well as the misuse of opioids, prescription pain relievers, tranquilizers, stimulants, and sedatives), substance use disorders, and substance use treatment among people 12 years of age and older. It Includes national estimates of any mental illness, serious mental illness, major depressive episode, use of mental health services and suicidal ideation among adults ages 18 or older and national estimates of major depressive episode, use of mental health services among adolescents aged 12 to 17. Trend information on these topics are also presented.